{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:45:20Z","timestamp":1788432320563,"version":"build-2803163510"},"reference-count":152,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semdiagpath.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1053\/j.semdp.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T08:15:32Z","timestamp":1480407332000},"page":"22-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders"],"prefix":"10.1053","volume":"34","author":[{"given":"Werner","family":"Kempf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.semdp.2016.11.005_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.005_bib2","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Skin Tumours","first-page":"179","article-title":"CD30+ T-cell lymphoproliferative disorders","author":"Kempf","year":"2006"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.005_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2001.tb03711.x","article-title":"Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand","volume":"941","author":"Kadin","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0037-1963(03)00138-0","article-title":"Systemic and primary cutaneous anaplastic large cell lymphomas","volume":"40","author":"Kadin","year":"2003","journal-title":"Semin Hematol"},{"issue":"12","key":"10.1053\/j.semdp.2016.11.005_bib6","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.semdp.2016.11.005_bib7","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/j.semdp.2016.11.005_bib8","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1111\/j.0303-6987.2006.00548.x","article-title":"CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators","volume":"33","author":"Kempf","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2016.11.005_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1600-0560.2007.00979.x","article-title":"Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin","volume":"35","author":"Werner","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2016.11.005_bib10","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"2008","author":"Swerdlow","year":"2008"},{"issue":"20","key":"10.1053\/j.semdp.2016.11.005_bib11","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/hon.897","article-title":"Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?","volume":"27","author":"Fornari","year":"2009","journal-title":"Hematol Oncol"},{"issue":"12","key":"10.1053\/j.semdp.2016.11.005_bib13","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2016.11.005_bib14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archderm.1995.01690230059010","article-title":"Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage","volume":"131","author":"Kerschmann","year":"1995","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000070960","article-title":"Posttransplant CD30+ anaplastic large cell lymphoma with skin and lymph node involvement","volume":"207","author":"Yurtsever","year":"2003","journal-title":"Dermatology"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1995.13.6.1343","article-title":"CD30\/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group","volume":"13","author":"Paulli","year":"1995","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdcr.2014.12.006","article-title":"Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab","volume":"1","author":"Hruska","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1053\/j.semdp.2016.11.005_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1352458516645868","article-title":"Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod","author":"Papathemeli","year":"2016","journal-title":"Mult Scler."},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00000478-199504000-00002","article-title":"Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma","volume":"19","author":"Mann","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0560.2007.00778.x","article-title":"The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants","volume":"35","author":"Massone","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2016.11.005_bib22","doi-asserted-by":"crossref","unstructured":"Kempf W, Kazakov DV, Paredes BE, Laeng HR, Palmedo G, Kutzner H. Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders, Dermatology 227 (4), 2013, 346\u2013352 http:\/\/dx.doi.org\/10.1159\/000355479.","DOI":"10.1159\/000355479"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.0303-6987.2004.00204.x","article-title":"Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia","volume":"31","author":"Lin","year":"2004","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00000372-199806000-00016","article-title":"Of lymphocytes and cutaneous epithelium: keratoacanthomatous hyperplasia in CD30+ lymphoproliferative disorders and CD30+ cells associated with keratoacanthoma","volume":"32","author":"Resnik","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2559.2001.01271.x","article-title":"Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features","volume":"39","author":"Wang","year":"2001","journal-title":"Histopathology"},{"issue":"9","key":"10.1053\/j.semdp.2016.11.005_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199309000-00001","article-title":"A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma","volume":"17","author":"Kinney","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2016.11.005_bib27","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/DAD.0b013e31824fec43","article-title":"Cutaneous intravascular anaplastic large T-cell lymphoma: a case report and review of the literature","volume":"34","author":"Iacobelli","year":"2012","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0560.2010.01538.x","article-title":"Cutaneous intravascular anaplastic large cell lymphoma","volume":"38","author":"Wang","year":"2011","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2016.11.005_bib29","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/PAS.0000000000000474","article-title":"Intralymphatic spread Is a common finding in cutaneous CD30+ lymphoproliferative disorders","volume":"39","author":"Ferrara","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2016.11.005_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/DAD.0000000000000377","article-title":"Occult dermal lymphatic involvement is frequent in primary cutaneous anaplastic large cell lymphoma","volume":"37","author":"Gratzinger","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1053\/j.semdp.2016.11.005_bib31","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3324\/haematol.2009.021428","article-title":"Disturbed expression of the T-cell receptor\/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations","volume":"95","author":"Geissinger","year":"2010","journal-title":"Haematologica"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib32","first-page":"1893","article-title":"TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation","volume":"150","author":"Felgar","year":"1997","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/bjd.14626","article-title":"KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma","volume":"175","author":"Battistella","year":"2016","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1053\/j.semdp.2016.11.005_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/cup.12719","article-title":"Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages","volume":"43","author":"De Souza","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/ajcp\/105.4.440","article-title":"CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases","volume":"105","author":"Macgrogan","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2016.11.005_bib36","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V87.8.3437.bloodjournal8783437","article-title":"The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin","volume":"87","author":"DeCoteau","year":"1996","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2016.11.005_bib37","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e3181648d6d","article-title":"Primary cutaneous ALCL with phosphorylated\/activated cytoplasmic ALK and novel phenotype: ema\/muc1+, cutaneous lymphocyte antigen negative","volume":"32","author":"Kadin","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/AJCP83AOQTMLOJTM","article-title":"Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Quintanilla-Martinez","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3324\/haematol.2009.015024","article-title":"Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases","volume":"95","author":"Lamant","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib41","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/DAD.0000000000000505","article-title":"Primary cutaneous anaplastic large-cell lymphoma with 6p25.3 rearrangement in a cardiac transplant recipient: a case report and review of the literature","volume":"38","author":"Olson","year":"2016","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/jid.2009.270","article-title":"Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators","volume":"130","author":"van Kester","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jdermsci.2011.07.004","article-title":"Differential patterns of CXCR3, CCR3, and CCR10 expression in mycosis fungoides, Sezary syndrome and CD30(+) lymphoproliferative disorders: immunohistochemical study of 43 samples","volume":"64","author":"Suga","year":"2011","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000431313","article-title":"Galectin-3 expression in primary cutaneous CD30-positive lymphoproliferative disorders and transformed mycosis fungoides","volume":"231","author":"Mitteldorf","year":"2015","journal-title":"Dermatology"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib47","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjd.13476","article-title":"Diagnostic and prognostic significance of CDKN2A\/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease","volume":"172","author":"Nicolae-Cristea","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib48","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/bjd.13808","article-title":"CD30-rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right","volume":"172","author":"Kadin","year":"2015","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1053\/j.semdp.2016.11.005_bib49","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1600-0625.2012.01548.x","article-title":"Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides","volume":"21","author":"Benner","year":"2012","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2133.2002.04839.x","article-title":"A case of Sezary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma","volume":"147","author":"Carrozza","year":"2002","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib51","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/bjd.13690","article-title":"Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides: a study of 66 cases","volume":"172","author":"Fauconneau","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib52","first-page":"553","article-title":"Cutaneous peripheral T-cell lymphomas, unspecified \/ NOS and rare subtypes: a heterogeneous group of challenging cutaneous lymphomas","volume":"147","author":"Kempf","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/DAD.0b013e318184bc3f","article-title":"A case of CD30+ nasal natural killer\/T-cell lymphoma","volume":"30","author":"Ferenczi","year":"2008","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0560.2008.01033.x","article-title":"Atypical intravascular CD30+ T-cell proliferation following trauma in a healthy 17-year-old male: first reported case of a potential diagnostic pitfall and literature review","volume":"36","author":"Baum","year":"2009","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/DAD.0b013e3182323119","article-title":"Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma","volume":"35","author":"Riveiro-Falkenbach","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib56","first-page":"586","article-title":"Intravascular T-cell lymphoma of the vulva, CD30 positive: a case report","volume":"30","author":"Zizi-Sermpetzoglou","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib57","first-page":"1148","article-title":"Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients","volume":"159","author":"Benner","year":"2008","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1053\/j.semdp.2016.11.005_bib58","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","article-title":"Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma","volume":"145","author":"Benner","year":"2009","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archdermatol.2009.74","article-title":"Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome","volume":"145","author":"Woo","year":"2009","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib60","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib61","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaad.2005.10.015","article-title":"Primary cutaneous T-cell lymphoma occurring after organ transplantation","volume":"54","author":"Ravat","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1053\/j.semdp.2016.11.005_bib62","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ajt.12281","article-title":"Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series","volume":"13","author":"Seckin","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign\u2014histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2016.11.005_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaad.2006.06.035","article-title":"Macaulay (1915\u20132006)\u2014in memoriam","volume":"55","author":"Burgdorf","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1053\/j.semdp.2016.11.005_bib65","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V94.9.3077","article-title":"CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: a clue to the pathophysiology of clinical regression","volume":"94","author":"Mori","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-0560.2001.280103.x","article-title":"Lymphomatoid papulosis and human herpesviruses\u2014a PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses","volume":"28","author":"Kempf","year":"2001","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1684\/ejd.2015.2707","article-title":"Human T-cell leukemia virus type 1-positive lymphomatoid papulosis","volume":"26","author":"Namba","year":"2016","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/carcin\/24.2.301","article-title":"Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin","volume":"24","author":"Kempf","year":"2003","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib69","first-page":"E15","article-title":"Regional lymphomatoid papulosis of the breast restricted to an area of prior radiotherapy","volume":"97","author":"Haro","year":"2016","journal-title":"Cutis"},{"key":"10.1053\/j.semdp.2016.11.005_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/1352458516642032","article-title":"Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient","author":"Matoula","year":"2016","journal-title":"Mult Scler"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.005_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/0190-9622(95)91811-6","article-title":"Lymphomatoid papulosis in children","author":"Zirbel","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib73","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.140.3.306","article-title":"Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases","volume":"140","author":"Nijsten","year":"2004","journal-title":"Arch Dermatol."},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib74","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jdcr.2015.04.014","article-title":"Lymphomatoid papulosis in a young adult of African descent","volume":"1","author":"Angra","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1053\/j.semdp.2016.11.005_bib75","article-title":"Angioinvasive lymphomatoid papulosis (type E): a first Japanese case","author":"Uchiyama","year":"2016","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib76","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1365-2133.1999.03218.x","article-title":"Regional lymphomatoid papulosis: a report of four cases","volume":"141","author":"Scarisbrick","year":"1999","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib77","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0190-9622(08)80202-2","article-title":"Pustular lymphomatoid papulosis in childhood","volume":"27","author":"Barnadas","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib78","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000342201","article-title":"Persistent agmination of lymphomatoid papulosis: an ongoing debate","volume":"225","author":"Pileri","year":"2012","journal-title":"Dermatology"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000081485","article-title":"Oral involvement in lymphomatoid papulosis. Report of two cases and review of the literature","volume":"210","author":"Pujol","year":"2005","journal-title":"Dermatology"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib81","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archderm.140.4.441","article-title":"Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C","volume":"140","author":"El Shabrawi-Caelen","year":"2004","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1053\/j.semdp.2016.11.005_bib82","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.005_bib83","doi-asserted-by":"crossref","DOI":"10.1097\/DAD.0b013e31825ba953","article-title":"Lymphomatoid papulosis type d: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma","author":"Cardoso","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.semdp.2016.11.005_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.12463","article-title":"Lymphomatoid papulosis type D: an aggressive histology for an indolent disease","author":"Bertolotti","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.005_bib85","article-title":"Angioinvasive lymphomatoid papulosis: another case of a newly described variant","author":"Sharaf","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.semdp.2016.11.005_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12773","article-title":"CD30+ lymphoproliferative disorder with spindle-cell morphology","author":"Martires","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00000372-199002000-00010","article-title":"Follicular lymphomatoid papulosis","volume":"12","author":"Requena","year":"1990","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib88","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/DAD.0000000000000395","article-title":"Follicular lymphomatoid papulosis: an eosinophilic-rich follicular subtype masquerading as folliculitis clinically and histologically","volume":"38","author":"Ross","year":"2016","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib89","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1309\/73DBA1EPAWF6F1T0","article-title":"Granulomatous eccrinotropic lymphomatoid papulosis","volume":"119","author":"Crowson","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib90","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/1066896915623364","article-title":"Pseudocarcinomatous hyperplasia hiding lymphomatoid papulosis: a \u201cLow-Power View\u201d Pitfall","volume":"24","author":"Bellafiore","year":"2016","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib91","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaad.2011.07.012","article-title":"In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients","volume":"66","author":"de Souza","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib92","first-page":"979","article-title":"Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta","volume":"136","author":"Varga","year":"1990","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2016.11.005_bib93","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/DAD.0000000000000375","article-title":"Characterization of primary cutaneous CD8+\/CD30+ lymphoproliferative disorders","volume":"37","author":"Martires","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib94","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2009.05.014","article-title":"Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients","volume":"61","author":"de Souza","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib95","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2133.2001.04324.x","article-title":"Lymphomatoid papulosis with a natural killer-cell phenotype","volume":"145","author":"Bekkenk","year":"2001","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib96","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/1523-1747.ep12337633","article-title":"Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype","volume":"109","author":"Kummer","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib97","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2340\/00015555-1145","article-title":"Lymphomatoid papulosis showing gammadelta T-cell phenotype","volume":"91","author":"Morimura","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib98","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-gamma expression in primary cutaneous T-cell lymphomas","volume":"37","author":"Rodriguez-Pinilla","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2016.11.005_bib99","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1600-0560.2006.00560.x","article-title":"Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders","volume":"33","author":"Greisser","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood-2001-12-0199","article-title":"Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin","volume":"100","author":"Steinhoff","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib101","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.0022-202X.2004.22304.x","article-title":"The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative)","volume":"122","author":"Gellrich","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib102","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.leukres.2012.12.001","article-title":"The significance of MUM1\/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: a study of 53 cases","volume":"37","author":"Kiran","year":"2013","journal-title":"Leuk Res"},{"issue":"8","key":"10.1053\/j.semdp.2016.11.005_bib103","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2016.11.005_bib104","first-page":"727","article-title":"Papulose lymphomatoide et lymphome anaplasique a grandes cellules","volume":"121","author":"Moreau Cabarrot","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"10.1053\/j.semdp.2016.11.005_bib105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1100\/tsw.2011.80","article-title":"Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma","volume":"11","author":"Diamantidis","year":"2011","journal-title":"Sci World J"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib106","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1309\/NNV4L5G5A0KF1T06","article-title":"Wright ED. CD8+ lymphomatoid papulosis and its differential diagnosis","volume":"125","author":"Magro","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib107","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/DAD.0b013e31827a0cda","article-title":"Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis","volume":"35","author":"Nambudiri","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib108","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semdp.2009.09.001","article-title":"Cutaneous CD30 lymphoproliferative disorders and similar conditions: a clinical and pathologic prospective on a complex issue","volume":"26","author":"Guitart","year":"2009","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib109","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPX4BXTP2QBRKO","article-title":"Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Sarantopoulos","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bjd.13024","article-title":"CD30-positive lymphoproliferative disorder in a red tattoo: regional lymphomatoid papulosis type C or pseudolymphoma?","volume":"171","author":"Haus","year":"2014","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1053\/j.semdp.2016.11.005_bib111","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/DAD.0000000000000109","article-title":"CD30 positive atypical lymphocytes in perniosis: a potential histopathologic pitfall in a benign condition","volume":"36","author":"Massey","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"10.1053\/j.semdp.2016.11.005_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12411","article-title":"Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders","volume":"41","author":"De Souza","year":"2014","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib113","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2133.2007.08073.x","article-title":"Bortezomib-associated cutaneous vasculitis","volume":"157","author":"Garcia-Navarro","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib114","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/DAD.0b013e31826bc1e5","article-title":"CD30+ lymphomatoid drug reactions","volume":"35","author":"Pulitzer","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1600-0560.2000.027005249.x","article-title":"Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions","volume":"27","author":"Su","year":"2000","journal-title":"J Cutan Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2016.11.005_bib116","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0b013e31824f4f66","article-title":"Pityriasis lichenoides et varioliformis acuta with numerous CD30+ cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases","volume":"36","author":"Kempf","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2016.11.005_bib117","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/DAD.0b013e3181f4d8c3","article-title":"Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis?","volume":"33","author":"Vonderheid","year":"2011","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib118","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0190-9622(87)70248-5","article-title":"Lymphomatoid papulosis. A follow-up study of 30 patients","volume":"17","author":"Thomsen","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1053\/j.semdp.2016.11.005_bib119","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/1097-0142(19921215)70:12<2951::AID-CNCR2820701236>3.0.CO;2-7","article-title":"Epidemiology of lymphomatoid papulosis","volume":"70","author":"Wang","year":"1992","journal-title":"Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib120","first-page":"197","article-title":"Lymphomatoid papulosis: a follow-up study of 41 patients","volume":"13","author":"Christensen","year":"1994","journal-title":"Semin Dermatol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib121","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2230.2008.03024.x","article-title":"Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients","volume":"34","author":"Kunishige","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib122","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/pbc.23103","article-title":"Cutaneous hematologic disorders in children","volume":"58","author":"Boccara","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib123","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2230.2011.04124.x","article-title":"Lymphomatoid papulosis: is a second lymphoma commoner among East Asians?","volume":"37","author":"Gan","year":"2012","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib124","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1634\/theoncologist.2015-0242","article-title":"Frequency and risk factors for associated lymphomas in patients with lymphomatoid papulosis","volume":"21","author":"Cordel","year":"2016","journal-title":"Oncologist"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.path.2014.02.001","article-title":"Cutaneous CD30-positive lymphoproliferative disorders","volume":"7","author":"Kempf","year":"2014","journal-title":"Surg Pathol Clin"},{"key":"10.1053\/j.semdp.2016.11.005_bib126","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12606","article-title":"New variant lymphomatoid papulosis type E preceding and coexisting with mycosis fungoides\u2014a case report and review of the literature","author":"Kiavash","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"17","key":"10.1053\/j.semdp.2016.11.005_bib127","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","article-title":"Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone","volume":"326","author":"Davis","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.humpath.2014.12.008","article-title":"Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin","volume":"46","author":"de la Garza Bravo","year":"2015","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1034\/j.1600-0560.2002.290507.x","article-title":"Fascin expression in CD30-positive cutaneous lymphoproliferative disorders","volume":"29","author":"Kempf","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3109\/10428194.2014.958821","article-title":"Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis","volume":"56","author":"Nikolaou","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2015.09.013","article-title":"Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients","volume":"74","author":"Wieser","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"32","key":"10.1053\/j.semdp.2016.11.005_bib132","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1053\/j.semdp.2016.11.005_bib133","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib134","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clml.2015.11.010","article-title":"Retrospective analysis of prognostic factors in 187 cases of transformed mycosis fungoides","volume":"16","author":"Talpur","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"10.1053\/j.semdp.2016.11.005_bib135","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","article-title":"CD30 expression and proliferative fraction in nontransformed mycosis fungoides","volume":"33","author":"Edinger","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib136","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamadermatol.2014.1629","article-title":"Brentuximab as a treatment for CD30+ mycosis fungoides and Sezary syndrome","volume":"151","author":"Mehra","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2016.11.005_bib137","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2133.2002.04961.x","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases","volume":"147","author":"Servitje","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2133.2009.09121.x","article-title":"Juvenile onset of primary low-grade cutaneous B-cell lymphoma","volume":"161","author":"Amitay-Laish","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib139","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2014.03.027","article-title":"Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant","volume":"71","author":"Kempf","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1053\/j.semdp.2016.11.005_bib140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.pai.0000143347.58174.91","article-title":"Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases","volume":"14","author":"Magro","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib141","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2014a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"14","key":"10.1053\/j.semdp.2016.11.005_bib142","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib143","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjh.13085","article-title":"CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia","volume":"167","author":"Slack","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.semdp.2016.11.005_bib144","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1600-0560.2002.290310.x","article-title":"Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma","volume":"29","author":"Herrera","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2016.11.005_bib145","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1365-4362.2003.01775.x","article-title":"Primary cutaneous CD30-positive large B-cell lymphoma associated with Epstein-Barr virus","volume":"42","author":"Oguz","year":"2003","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2016.11.005_bib146","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.iac.2014.01.006","article-title":"CD30 in systemic mastocytosis","volume":"34","author":"van Anrooij","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib147","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/PAI.0000000000000048","article-title":"CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases","volume":"22","author":"Alimchandani","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2016.11.005_bib148","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2001.tb03711.x","article-title":"Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by TGF-beta and CD30 ligand","volume":"941","author":"Kadin","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"19","key":"10.1053\/j.semdp.2016.11.005_bib149","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1158\/1078-0432.CCR-09-0162","article-title":"A phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders","volume":"15","author":"Duvic","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1053\/j.semdp.2016.11.005_bib150","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1002965","article-title":"Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas","volume":"363","author":"Younes","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.semdp.2016.11.005_bib151","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11899-011-0096-8","article-title":"CD30+ neoplasms of the skin","volume":"6","author":"Duvic","year":"2011","journal-title":"Curr Hematol Malig Rep"},{"issue":"5","key":"10.1053\/j.semdp.2016.11.005_bib152","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000347192","article-title":"Targeting CD30 in malignant tissues: challenges in detection and clinical applications","volume":"80","author":"Wasik","year":"2013","journal-title":"Pathobiology"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257016300958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257016300958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T21:23:39Z","timestamp":1718918619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257016300958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0740257016300958"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2016.11.005","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}